|
The announcement was made after market hours yesterday, 18 July 2016.
Meanwhile, the S&P BSE Sensex was up 60.32 points or 0.22% at 27,806.98.
On BSE, so far 19,000 shares were traded in the counter as against average daily volume of 22,650 shares in the past one quarter. The stock hit a high of Rs 102 and a low of Rs 99.85 so far during the day. The stock had hit a record high of Rs 167.90 on 13 January 2016. The stock had hit a 52-week low of Rs 60.50 on 25 August 2015. The stock had outperformed the market over the past one month till 18 July 2016, gaining 12.78% compared with Sensex's 4.21% rise. The scrip had, however, underperformed the market in past one quarter, sliding 3.44% as against Sensex's 7.48% rise.
The small-cap company has equity capital of Rs 14.17 crore. Face value per share is Rs 10.
On consolidated basis, Bal Pharma reported net loss of Rs 3.15 crore in Q4 March 2016 compared with net profit of Rs 0.34 crore in Q4 March 2015. Net sales rose 7.9% to Rs 53.88 crore in Q4 March 2016 over Q4 March 2015.
Bal Pharma is a fully integrated and leading Indian pharmaceutical company specializing in prescription drugs, generic, OTC products, intravenous infusions, bulk drugs (APIs) and also Ayurvedic formulations.
|